These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 20473062

  • 21. Introduction of vagus nerve stimulation into a maintenance electroconvulsive therapy regimen: a case study and cost analysis.
    Warnell RL, Elahi N.
    J ECT; 2007 Jun; 23(2):114-9. PubMed ID: 17548984
    [Abstract] [Full Text] [Related]

  • 22. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Jun; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 23. Cardiac effects of vagus nerve stimulation in patients with major depression.
    Sperling W, Reulbach U, Bleich S, Padberg F, Kornhuber J, Mueck-Weymann M.
    Pharmacopsychiatry; 2010 Jan; 43(1):7-11. PubMed ID: 20013552
    [Abstract] [Full Text] [Related]

  • 24. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M, Kopecek M, Novak T, Stopkova P, Sos P, Kozeny J, Brunovsky M, Höschl C.
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [Abstract] [Full Text] [Related]

  • 25. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.
    Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, Martinez JM, George MS.
    J Clin Psychiatry; 2005 Sep; 66(9):1097-104. PubMed ID: 16187765
    [Abstract] [Full Text] [Related]

  • 26. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K.
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [Abstract] [Full Text] [Related]

  • 27. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.
    Rush AJ, Siefert SE.
    Exp Neurol; 2009 Sep; 219(1):36-43. PubMed ID: 19397908
    [Abstract] [Full Text] [Related]

  • 28. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
    Nierenberg AA, Alpert JE, Gardner-Schuster EE, Seay S, Mischoulon D.
    Biol Psychiatry; 2008 Sep 15; 64(6):455-60. PubMed ID: 18571625
    [Abstract] [Full Text] [Related]

  • 29. The efficacy of vagal nerve stimulation in children with pharmacoresistant epilepsy: practical experience at a Turkish tertiary referral center.
    Arhan E, Serdaroglu A, Kurt G, Bilir E, Durdağ E, Erdem A, Aksakal FN, Ozcelik A, Baykaner K.
    Eur J Paediatr Neurol; 2010 Jul 15; 14(4):334-9. PubMed ID: 19850501
    [Abstract] [Full Text] [Related]

  • 30. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L, Pitrosky B, Padmanabhan SK, Germain JM, Tourian KA.
    Int Clin Psychopharmacol; 2007 Nov 15; 22(6):338-47. PubMed ID: 17917552
    [Abstract] [Full Text] [Related]

  • 31. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH.
    Biol Psychiatry; 2004 Sep 15; 56(6):418-26. PubMed ID: 15364040
    [Abstract] [Full Text] [Related]

  • 32. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 15; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 33. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE, Schwartz T, Sackeim HA.
    Arch Gen Psychiatry; 2010 May 15; 67(5):507-16. PubMed ID: 20439832
    [Abstract] [Full Text] [Related]

  • 34. Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry.
    Levy ML, Levy KM, Hoff D, Amar AP, Park MS, Conklin JM, Baird L, Apuzzo ML.
    J Neurosurg Pediatr; 2010 Jun 15; 5(6):595-602. PubMed ID: 20515333
    [Abstract] [Full Text] [Related]

  • 35. Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial.
    Schrader LM, Cook IA, Miller PR, Maremont ER, DeGiorgio CM.
    Epilepsy Behav; 2011 Nov 15; 22(3):475-8. PubMed ID: 21820361
    [Abstract] [Full Text] [Related]

  • 36. VNS and depression: current status and future directions.
    Walsh SP, Kling MA.
    Expert Rev Med Devices; 2004 Sep 15; 1(1):155-60. PubMed ID: 16293018
    [Abstract] [Full Text] [Related]

  • 37. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A, Pluck G, Eranti SV, Landau S, Purvis R, Brown RG, Curtis V, Howard R, Philpot M, McLoughlin DM.
    Psychol Med; 2008 Mar 15; 38(3):323-33. PubMed ID: 17935639
    [Abstract] [Full Text] [Related]

  • 38. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V, Dinan TG, Scott L, Corcoran C.
    Biol Psychiatry; 2005 Dec 15; 58(12):963-8. PubMed ID: 16005439
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression.
    Cohen RB, Boggio PS, Fregni F.
    Depress Anxiety; 2009 Dec 15; 26(7):682-8. PubMed ID: 19170101
    [Abstract] [Full Text] [Related]

  • 40. Transcranial direct current stimulation in a patient with therapy-resistant major depression.
    Palm U, Keeser D, Schiller C, Fintescu Z, Reisinger E, Baghai TC, Mulert C, Padberg F.
    World J Biol Psychiatry; 2009 Dec 15; 10(4 Pt 2):632-5. PubMed ID: 19995213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.